The death domain superfamily in intracellular signaling of apoptosis and inflammation

Annual Review of Immunology

Volumn 25, Issue , 2007, Pages 561-586

  Hyun, Ho Park ^a   Lo, Yu Chih ^a   Lin, Su Chang ^a   Wang, Liwei ^a   Jin, Kuk Yang ^a,b   Wu, Hao ^a  

^a Weill Cornell Graduate School of Biomedical Sciences   (United States)

^b Soongsil University   (South Korea)

Author keywords

Caspase recruitment domain (CARD); Crystal structure; Death domain (DD); Death effector domain (DED); NMR structure; Pyrin domain (PYD); Tandem DED

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME;

APOPTOSIS; ENZYME ACTIVATION; HUMAN; INFLAMMATION; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CARD SIGNALING ADAPTOR PROTEINS; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEINS; EVOLUTION, MOLECULAR; HUMANS; INFLAMMATION; MULTIPROTEIN COMPLEXES; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34247842740     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.25.022106.141656     Document Type: Review

References (141)

1. Kerr JF, Wyllie AH, Currie AR. 1972. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26:239-57
2. Duvall E, Wyllie AH. 1986. Death and the cell. Immunol. Today 7:115-19
3. Rathmell JC, Thompson CB. 2002. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell 109(Suppl.):S97-107
4. Thompson CB. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-61
5. Salvesen GS. 2002. Caspases and apoptosis. Essays Biochem. 38:9-19
6. Riedl SJ, Shi Y. 2004. Molecular mechanisms of caspase regulation during apoptosis. Nat. Rev. Mol. Cell Biol. 5:897-907
7. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M. 1997. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388:548-54
8. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M. 1997. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 91:243-52
9. Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M. 1997. Identification and characterization of an IκB kinase. Cell 90:373-83
10. Krappmann D, Hatada EN, Tegethoff S, Li J, Hippel A, et al. 2000. The IκB kinase (IKK) complex is tripartite and contains IKK gamma but not IKAP as a regular component. J. Biol. Chem. 275:29779-87
11. Stancovski I, Baltimore D. 1997. NF-kB activation: the IkB kinase revealed? Cell 91:299-302
12. Beg AA, Baltimore D. 1996. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274:782-84
13. Liu ZG, Hsu H, Goeddel DV, Karin M. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB; activation prevents cell death. Cell 87:565-76
14. Baeuerle PA, Baltimore D. 1996. NF-κ: ten years after. Cell 87:13-20
15. Martinon F, Tschopp J. 2004. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117:561-74
16. Reed JC, Doctor KS, Godzik A. 2004. The domains of apoptosis: a genomics perspective. Sci. STKE 2004:re9
17. Kohl A, Grutter MG. 2004. Fire and death: The pyrin domain joins the death-domain superfamily. C. R. Biol. 327:1077-86
18. Yan N, Shi Y. 2005. Mechanisms of apoptosis through structural biology. Annu. Rev. Cell Dev. Biol. 21:35-56
19. McEntyre JR, Gibson TJ. 2004. Patterns and clusters within the PSM column in TiBS, 1992-2004. Trends Biochem. Sci. 29:627-33
20. Hu S, Vincenz C, Buller M, Dixit VM. 1997. Anovel family of viral death effector domaincontaining molecules that inhibit both CD-95- and tumor necrosis factor receptor-1-induced apoptosis. J. Biol. Chem. 272:9621-24
21. Bertin J, Armstrong RC, Ottilie S, Martin DA, Wang Y, et al. 1997. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFRlinduced apoptosis. Proc. Natl. Acad. Sci. USA 94:1172-76
22. Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, et al. 1997. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386:517-21
23. Johnston JB, Barrett JW, Nazarian SH, Goodwin M, Ricuttio D, et al. 2005. A poxvirus-encoded pyrin domain protein interacts with ASC-1 to inhibit host inflammatory and apoptotic responses to infection. Immunity 23:587-98
24. Huang B, Eberstadt M, Olejniczak ET, Meadows RP, Fesik SW. 1996. NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain. Nature 384:638-41
25. Eberstadt M, Huang B, Chen Z, Meadows RP, Ng SC, et al. 1998. NMR structure and mutagenesis of the FADD (Mort1) death-effector domain. Nature 392:941-45
26. Chou JJ, Matsuo H, Duan H, Wagner G. 1998. Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment. Cell 94:171-80
27. Hiller S, Kohl A, Fiorito F, Herrmann T, Wider G, et al. 2003. NMR structure of the apoptosis- and inflammation-related NALP1 pyrin domain. Structure 11:1199-205
28. Banner DW, D'Arcy A, Janes W, Gentz R, Schoenfeld HJ, et al. 1993. Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell 73:431-45
29. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, et al. 1995. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14:5579-88
30. Tartaglia LA, Ayres TM, Wong GH, Goeddel DV. 1993. A novel domain within the 55 kd TNF receptor signals cell death. Cell 74:845-53
31. Itoh N, Nagata S. 1993. A novel protein domain required for apoptosis: mutational analysis of human Fas antigen. J. Biol. Chem. 268:10932-37
32. Wajant H. 2002. The Fas signaling pathway: more than a paradigm. Science 296:1635-36
33. Boldin MP, Mett IL, Varfolomeev EE, Chumakov I, Shemer-Avni Y, et al. 1995. Self-association of the "death domains" of the p55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and Fas/APO1 effects. J. Biol. Chem. 270:387-91
34. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM. 1995. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81:505-12
35. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, et al. 1996. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85:817-27
36. Boldin MP, Goncharov TM, Goltsev YV, Wallach D. 1996. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85:803-15
37. Salvesen GS, Dixit VM. 1999. Caspase activation: the induced-proximity model. Proc. Natl. Acad. Sci. USA 96:10964-67
38. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, et al. 1997. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 16:2794-804
39. Shi Y. 2004. Caspase activation: revisiting the induced proximity model. Cell 117:855-58
40. Micheau O, Tschopp J. 2003. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114:181-90
41. Thome M, Tschopp J. 2001. Regulation of lymphocyte proliferation and death by FLIP. Nat. Rev. Immunol. 1:50-58
42. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, et al. 1997. Inhibition of death receptor signals by cellular FLIP. Nature 388:190-95
43. Shu HB, Halpin DR, Goeddel DV. 1997. Casper is a FADD- and caspase-related inducer of apoptosis. Immunity 6:751-63
44. Srinivasula SM, Ahmad M, Ottilie S, Bullrich F, Banks S, et al. 1997. FLAME-1, a novel FADD-like antiapoptotic molecule that regulates Fas/TNFR1-induced apoptosis. J. Biol. Chem. 272:18542-45
45. Inohara N, Koseki T, Hu Y, Chen S, Nunez G. 1997. CLARP, a death effector domain-containing protein interacts with caspase-8 and regulates apoptosis. Proc. Natl. Acad. Sci. USA 94:10717-22
46. Goltsev YV, Kovalenko AV, Arnold E, Varfolomeev EE, Brodianskii VM, Wallach D. 1997. CASH, a novel caspase homologue with death effector domains. J. Biol. Chem. 272:19641-44
47. Han DK, Chaudhary PM, Wright ME, Friedman C, Trask BJ, et al. 1997. MRIT, a novel death-effector domain-containing protein, interacts with caspases and BclXL and initiates cell death. Proc. Natl. Acad. Sci. USA 94:11333-38
48. Hu S, Vincenz C, Ni J, Gentz R, Dixit VM. 1997. I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis. J. Biol. Chem. 272:17255-57
49. Rasper DM, Vaillancourt JP, Hadano S, Houtzager VM, Seiden I, et al. 1998. Cell death attenuation by 'Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex. Cell Death Differ. 5:271-88
50. Garvey TL, Bertin J, Siegel RM, Wang GH, Lenardo MJ, Cohen JI. 2002. Binding of FADD and caspase-8 to molluscum contagiosum virus MC159 v-FLIP is not sufficient for its antiapoptotic function. J. Virol. 76:697-706
51. Shisler JL, Moss B. 2001. Molluscum contagiosum virus inhibitors of apoptosis: The MC159 v-FLIP protein blocks Fas-induced activation of procaspases and degradation of the related MC160 protein. Virology 282:14-25
52. Searles RP, Bergquam EP, Axthelm MK, Wong SW. 1999. Sequence and genomic analysis of a Rhesus macaque rhadinovirus with similarity to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J. Virol. 73:3040-53
53. Poppema S, Maggio E, van den Berg A. 2004. Development of lymphoma in autoimmune lymphoproliferative syndrome (ALPS) and its relationship to Fas gene mutations. Leuk. Lymph. 45:423-31
54. Rieux-Laucat F, Le Deist F, Fischer A. 2003. Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways. Cell Death Differ. 10:124-33
55. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middelton LA, et al. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lyphoproliferative syndrome. Cell 81:935-46
56. Sneller MC, Wang J, Dale JK, Strober W, Middelton LA, et al. 1997. Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood 89:1341-48
57. Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IA, Debatin KM, et al. 1995. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347-49
58. Kasahara Y, Wada T, Niida Y, Yachie A, Seki H, et al. 1998. Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder. Int. Immunol. 10:195-202
59. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. 1997. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90:405-13
60. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, et al. 1997. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479-89
61. Adams JM, Cory S. 2002. Apoptosomes: engines for caspase activation. Curr. Opin. Cell Biol. 14:715-20
62. Wang L, Miura M, Bergeron L, Zhu H, Yuan J. 1994. Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 78:739-50
63. Tinel A, Tschopp J. 2004. The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 304:843-46
64. Berube C, Boucher LM, Ma W, Wakeham A, Salmena L, et al. 2005. Apoptosis caused by p53-induced protein with death domain (PIDD) depends on the death adapter protein RAIDD. Proc. Natl. Acad. Sci. USA 102:14314-20
65. Lin Y, Ma W, Benchimol S. 2000. Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis. Nat. Genet. 26:122-27
66. Duan H, Dixit VM. 1997. RAIDD is a new 'death' adaptor molecule. Nature 385:86-89
67. Lassus P, Opitz-Araya X, Lazebnik Y. 2002. Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 297:1352-54
68. Janssens S, Tinel A, Lippens S, Tschopp J. 2005. PIDD mediates NF-κB activation in response to DNA damage. Cell 123:1079-92
69. Fitzgerald KA, Chen ZJ. 2006. Sorting out Toll signals. Cell 125:834-36
70. Chen ZJ. 2005. Ubiquitin signaling in the NF-κB pathway. Nat. Cell Biol. 7:758-65
71. Sun H, Bristow BN, Qu G, Wasserman SA. 2002. A heterotrimeric death domain complex in Toll signaling. Proc. Natl. Acad. Sci. USA 99:12871-76
72. Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA. 1996. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86:973-83
73. Letsou A, Alexander S, Orth K, Wasserman SA. 1991. Genetic and molecular characterization of tube, a Drosophila gene maternally required for embryonic dorsoventral polarity. Proc. Natl. Acad. Sci. USA 88:810-14
74. Thome M. 2004. CARMA1, BCL-10 and MALTI in lymphocyte development and activation. Nat. Rev. Immunol. 4:348-59
75. Gaide O, Martinon F, Micheau O, Bonnet D, Thome M, Tschopp J. 2001. Carma1, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF-κB activation. FEBS Lett. 496:121-27
76. Gaide O, Favier B, Legler DF, Bonnet D, Brissoni B, et al. 2002. CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-κ activation. Nat. Immunol. 3:836-43
77. Lucas PC, Yonezumi M, Inohara N, McAllister-Lucas LM, Abazeed ME, et al. 2001. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-κB signaling pathway. J. Biol. Chem. 276:19012-19
78. Uren AG, O'Rourke K, Aravind LA, Pisabarro MT, Seshagiri S, et al. 2000. Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol. Cell 6:961-67
79. Budd RC, Yeh WC, Tschopp J. 2006. cFLIP regulation of lymphocyte activation and development. Nat. Rev. Immunol. 6:196-204
80. Sun L, Deng L, Ea CK, Xia ZP, Chen ZJ. 2004. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell 14:289-301
81. Inohara N, Koseki T, del Peso L, Hu Y, Yee C, et al. 1999. Nodi, an Apaf-1 -like activator of caspase-9 and nuclear factor-κB. J. Biol. Chem. 274:14560-67
82. Inohara N, del Peso L, Koseki T, Chen S, Nunez G. 1998. RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95 mediated apoptosis. J. Biol. Chem. 273:12296-300
83. Inohara N, Koseki T, Lin J, del Peso L, Lucas PC, et al. 2000. An induced proximity model for NF-κ activation in the Nod1/RICK and RIP signaling pathways. J. Biol. Chem. 275:27823-31
84. Thome M, Hofmann K, Burns K, Martinon F, Bodmer JL, et al. 1998. Identification of CARDIAK, a RIP-like kinase that associates with caspase-1. Curr. Biol. 8:885-88
85. Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G. 2001. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-κB. J. Biol. Chem. 276:4812-18
86. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, et al. 2001. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411:603-6
87. Humke EW, Shriver SK, Starovasnik MA, Fairbrother WJ, Dixit VM. 2000. ICEBERG: a novel inhibitor of interleukin-1β generation. Cell 103:99-111
88. Lee SH, Stehlik C, Reed JC. 2001. Cop, a caspase recruitment domain-containing protein and inhibitor of caspase-1 activation processing. J. Biol. Chem. 276:34495-500
89. Meylan E, Tschopp J, Karin M. 2006. Intracellular pattern recognition receptors in the host response. Nature 442:39-44
90. Seth RB, Sun L, Ea CK, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF 3. Cell 122:669-82
91. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, et al. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167-72
92. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, et al. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6:981-88
93. Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB. 2005. VISA is an adapter protein required for virus-triggered IFN-β signaling. Mol. Cell 19:727-40
94. Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, et al. 2004. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-β promoter. Proc. Natl. Acad. Sci. USA 101:17264-69
95. Yoneyama M, Kikuchi M, Matsumoto K, Imaizumi T, Miyagishi M, et al. 2005. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol. 175:2851-58
96. Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, et al. 2005. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23:19-28
97. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-5
98. Rothenfusser S, Goutagny N, DiPerna G, Gong M, Monks BG, et al. 2005. The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. J. Immunol. 175:5260-68
99. Martinon F, Burns K, Tschopp J. 2002. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol. Cell 10:417-26
100. Chu ZL, Pio F, Xie Z, Welsh K, Krajewska M, et al. 2001. A novel enhancer of the Apaf1 apoptosome involved in cytochrome c-dependent caspase activation and apoptosis. J. Biol. Chem. 276:9239-45
101. Hlaing T, Guo RF, Dilley KA, Loussia JM, Morrish TA, et al. 2001. Molecular cloning and characterization of DEFCAP-L and -S, two isoforms of a novel member of the mammalian Ced-4 family of apoptosis proteins. J. Biol. Chem. 276:9230-38
102. Masumoto J, Taniguchi S, Ayukawa K, Sarvotham H, Kishino T, et al. 1999. ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells. J. Biol. Chem. 274:33835-38
103. Sukits SF, Lin LL, Hsu S, Malakian K, Powers R, Xu GY. 2001. Solution structure of the tumor necrosis factor receptor-1 death domain. J. Mol. Biol. 310:895-906
104. Liepinsh E, Ilag LL, Otting G, Ibanez CF. 1997. NMR structure of the death domain of the p75 neurotrophin receptor. EMBO J. 16:4999-5005
105. Lasker MV, Gajjar MM, Nair SK. 2005. Cutting edge: molecular structure of the IL-1R-associated kinase-4 death domain and its implications for TLR signaling. J. Immunol. 175:4175-79
106. Jeong EJ, Bang S, Lee TH, Park YI, Sim WS, Kim KS. 1999. The solution structure of FADD death domain: structural basis of death domain interactions of Fas and FADD. J. Biol. Chem. 274:16337-42
107. Berglund H, Olerenshaw D, Sankar A, Federwisch M, McDonald NQ, Driscoll PC. 2000. The three-dimensional solution structure and dynamic properties of the human FADD death domain. J. Mol. Biol. 302:171-88
108. Park HH, Wu H. 2006. Crystal structure of RAIDD death domain implicates potential mechanism of PIDDosome assembly. J. Mol. Biol. 357:358-64
109. Xiao T, Towb P, Wasserman SA, Sprang SR. 1999. Three-dimensional structure of a complex between the death domains of Pelle and Tube. Cell 99:545-55
110. Sun H, Towb P, Chiem DN, Foster BA, Wasserman SA. 2004. Regulated assembly of the Toll signaling complex drives Drosophila dorsoventral patterning. EMBO J. 23:100-10
111. Martin DA, Zheng L, Siegel RM, Huang B, Fisher GH, et al. 1999. Defective CD95/APO-l/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia. Proc. Natl. Acad. Sci. USA 96:4552-57
112. Hill JM, Morisawa G, Kim T, Huang T, Wei Y, Werner MH. 2004. Identification of an expanded binding surface on the FADD death domain responsible for interaction with CD95/Fas. J. Biol. Chem. 279:1474-81
113. Park A, Baichwal VR. 1996. Systematic mutational analysis of the death domain of the tumor necrosis factor receptor-1-associated protein TRADD. J. Biol. Chem. 271:9858-62
114. Telliez JB, Xu GY, Woronicz JD, Hsu S, Wu JL, et al. 2000. Mutational analysis and NMR studies of the death domain of the tumor necrosis factor receptor-1. J. Mol. Biol. 300:1323-33
115. Weber CH, Vincenz C. 2001. A docking model of key components of the DISC complex: death domain superfamily interactions redefined. FEBS Lett. 492:171-76
116. Yang JK, Wang L, Zheng L, Wan F, Ahmed M, et al. 2005. Crystal structure of MC159 reveals molecular mechanism of DISC assembly and FLIP inhibition. Mol. Cell 20:939-49
117. Sandu C, Morisawa G, Wegorzewska I, Huang T, Arechiga AF, et al. 2006. FADD self-association is required for stable interaction with an activated death receptor. Cell Death Differ. 13:2052-61
118. Hill JM, Vaidyanathan H, Ramos JW, Ginsberg MH, Werner MH. 2002. Recognition of ERK MAP kinase by PEA-15 reveals a common docking site within the death domain and death effector domain. EMBO J. 21:6494-504
119. Carrington PE, Sandu C, Wei Y, Hill JM, Morisawa G, et al. 2006. The structure of FADD and its mode of interaction with procaspase-8. Mol. Cell 22:599-610
120. Li FY, Jeffrey PD, Yu JW, Shi Y. 2006. Crystal structure of a viral FLIP: insights into FLIP-mediated inhibition of death receptor signaling. J. Biol. Chem. 281:2960-68
121. Muppidi JR, Lobito AA, Ramaswamy M, Yang JK, Wang L, et al. 2 006. Homotypic FADD interactions through a conserved RXDLL motif are required for death receptor-induced apoptosis. Cell Death Differ. 13:1641-50
122. Vaughn DE, Rodriguez J, Lazebnik Y, Joshua-Tor L. 1999. Crystal structure of Apaf-1 caspase recruitment domain: an α-helical Greek key fold for apoptotic signaling. J. Mol. Biol. 293:439-47
123. Riedl SJ, Li W, Chao Y, Schwarzenbacher R, Shi Y. 2005. Structure of the apoptotic protease-activating factor 1 bound to ADP. Nature 434:926-33
124. Qin H, Srinivasula SM, Wu G, Fernandes-Alnemri T, Alnemri ES, Shi Y. 1999. Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1. Nature 399:549-57
125. Yan N, Chai J, Lee ES, Gu L, Liu Q, et al. 2005. Structure of the CED-4-CED-9 complex provides insights into programmed cell death in Caenorhabditis elegans. Nature 43 7:831-37
126. Yu X, Acehan D, Menetret JF, Booth CR, Ludtke SJ, et al. 2005. A structure of the human apoptosome at 12.8 Å resolution provides insights into this cell death platform. Structure 13:1725-35
127. Shiozaki EN, Chai J, Shi Y. 2002. Oligomerization and activation of caspase-9, induced by Apaf-1 CARD. Proc. Natl. Acad. Sci. USA 99:4197-202
128. Liepinsh E, Barbals R, Dahl E, Sharipo A, Staub E, Otting G. 2003. The death-domain fold of the ASC PYRIN domain, presenting a basis for PYRIN/PYRIN recognition. J. Mol. Biol. 332:1155-63
129. Eliezer D. 2003. Folding pyrin into the family. Structure 11:1190-91
130. Bertin J, DiStefano PS. 2000. The PYRIN domain: a novel motif found in apoptosis and inflammation proteins. Cell Death Differ. 7:1273-74
131. Martinon F, Hofmann K, Tschopp J. 2001. The pyrin domain: a possible member of the death domain-fold family implicated in apoptosis and inflammation. Curr. Biol. 11:R118-20
132. Pawlowski K, Pio F, Chu Z, Reed JC, Godzik A. 2001. PAAD: a new protein domain associated with apoptosis, cancer and autoimmune diseases. Trends Biochem. Sci. 26:85-87
133. Weber CH, Vincenz C. 2001. The death domain superfamily: a tale of two interfaces? Trends Biochem. Sci. 26:475-81
134. Kaufmann M, Bozic D, Briand C, Bodmer JL, Zerbe O, et al. 2002. Identification of a basic surface area of the FADD death effector domain critical for apoptotic signaling. FEBS Lett. 527:250-54
135. Gumucio DL, Diaz A, Schaner P, Richards N, Babcock C, et al. 2002. Fire and ICE: the role of pyrin domain-containing proteins in inflammation and apoptosis. Clin. Exp. Rheumatol. 20:S45-53
136. Moriya M, Taniguchi S, Wu P, Liepinsh E, Otting G, Sagara J. 2005. Role of charged and hydrophobic residues in the oligomerization of the PYRIN domain of ASC. Biochemistry 44:575-83
137. Consortium TFF. 1997. A candidate gene for familial Mediterranean fever. Nat. Genet. 17:25-31
138. Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. 2 001. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat. Genet. 29:301-5
139. Kastner DL, O'Shea JJ. 2001. A fever gene comes in from the cold. Nat. Genet. 29:241-42
140. Ting JP, Kastner DL, Hoffman HM. 2006. CATERPILLERs, pyrin and hereditary immunological disorders. Nat. Rev. Immunol. 6:183-95
141. Nam YJ, Mani K, Ashton AW, Peng CF, Krishnamurthy B, et al. 2004. Inhibition of both the extrinsic and intrinsic death pathways through nonhomotypic death-fold interactions. Mol. Cell 15:901-12